The Journal of Urology
Volume 175, Issue 2 , Pages 500-504, February 2006

Obesity, Serum Prostate Specific Antigen and Prostate Size: Implications for Prostate Cancer Detection

  • Stephen J. Freedland

      Affiliations

    • Department of Urology, Johns Hopkins School of Medicine, Baltimore, Maryland
    • Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
    • Corresponding Author InformationCorrespondence and requests for reprints: Division of Urology, Duke University School of Medicine, Box 3850, DUMC, Durham, North Carolina 27710 (telephone: 919-668-8361FAX: 919-668-7117
  • ,
  • Elizabeth A. Platz

      Affiliations

    • Department of Urology, Johns Hopkins School of Medicine, Baltimore, Maryland
    • Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, Maryland
  • ,
  • Joseph C. Presti Jr

      Affiliations

    • Department of Urology, Stanford University School of Medicine and Department of Surgery, Veterans Administration Medical Center, Palo Alto
  • ,
  • William J. Aronson

      Affiliations

    • Department of Surgery, Veterans Administration Greater Los Angeles Healthcare System and Department of Urology, University of California-Los Angeles School of Medicine, Los Angeles
  • ,
  • Christopher L. Amling

      Affiliations

    • Department of Urology, San Diego Naval Hospital, San Diego
  • ,
  • Christopher J. Kane

      Affiliations

    • Department of Surgery, Veterans Administration Medical Center San Francisco and Department of Urology, University of California, School of Medicine, San Francisco, California
  • ,
  • Martha K. Terris

      Affiliations

    • Department of Surgery, Veterans Administration Medical Center and Section of Urology, Medical College of Georgia, Augusta, Georgia

Received 9 March 2005

Purpose

Obesity has been associated with lower serum testosterone, theoretically resulting in decreased PSA production. Obesity has also been associated with prostatic enlargement, making the detection of existent cancer more difficult. Together these findings would result in an apparent protective effect of obesity on prostate cancer risk due to technical detection issues unrelated to cancer biology. We examined the association between BMI, and PSA and prostate weight in a cohort of men undergoing RP.

Materials and Methods

We evaluated the association of BMI with prostate weight and PSA using linear regression, adjusting for patient age at RP, year of RP, race, and pathological stage and grade in 1,414 men treated with RP between 1988 and 2004 at the 5 equal access medical centers that comprise the Shared Equal Access Regional Cancer Hospital Database.

Results

On multivariate analysis increasing BMI was associated with increasing prostate weight but only in men younger than 63 years and not in men 63 years or older (p-trend <0.001 and 0.44, respectively). In men younger than 63 years mean multivariate adjusted prostate weight ± SE in those with a BMI of less than 25 vs 30 to 34.9 kg/m2 was 33.8 ± 1.4 vs 41.4 ± 1.6 gm. There was no significant association between BMI and preoperative PSA (p-trend = 0.70).

Conclusions

In a cohort of men undergoing RP obesity was associated with larger prostate size but only in younger men. There was no association between BMI and PSA. Assuming equal PSA, the degree of prostatic enlargement observed in younger obese men in this study would be expected to result in a modest decrease in the odds of detecting prostate cancer in a contemporary series of PSA screened men due to the decreased sensitivity of cancer detection related to larger prostate size. Obesity may appear protective for prostate cancer in younger men due to technical issues unrelated to cancer biology.

Key Words:  prostate , prostatic neoplasms , prostatectomy , obesity , prostate-specific antigen

Abbreviations and Acronyms:  BMI, body mass index , PSA, prostate specific antigen , RP, radical prostatectomy , SEARCH, Shared Equal Access Regional Cancer Hospital

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Study received Institutional Review Board approval at each institution.

 Supported by the Department of Veterans Affairs, National Institutes of Health R01CA100938 (WJA), National Institutes of Health Specialized Programs of Research Excellence Grant P50 CA92131-01A1 (WJA), National Institutes of Health Specialized Programs of Research Excellence Grant Career Development Award P50CA58236 (EAP), the Georgia Cancer Coalition (MKT), Center for Prostate Disease Research (CPDR), a grant from the United States Army Medical Research and Materiel Command (CLA), Department of Defense, Prostate Cancer Research Program PC030666 (SJF) and DAMD 17-03-1-0273 (EAP), and an American Foundation for Urologic Disease/American Urological Association Education and Research Scholarship Award (SJF).

 Views, opinions and endorsements are those of the authors.

PII: S0022-5347(05)00162-X

doi:10.1016/S0022-5347(05)00162-X

The Journal of Urology
Volume 175, Issue 2 , Pages 500-504, February 2006